Table 2.
Clinical characteristic | Entire cohort (n=19) |
Ischemic subgroup | ||
---|---|---|---|---|
CAD− / Lactate elution− (n=5) |
CAD+/ Lactate elution− (n=7) |
CAD+/ Lactate elution+ (n=7) |
||
Angiography | ||||
No. diseased vessels | ||||
0 | 5 (26) | 5 (100) | NA | NA |
1 | 10(53) | NA | 4 (57) | 6 (86) |
2 | 3 (16) | NA | 3 (43) | 0 |
3 | 1 (5) | NA | 0 | 1 (14) |
Diseased vessel | ||||
LAD | 8 (57) | NA | 2 (29) | 6 (86) |
LCx | 5 (36) | NA | 4 (57) | 1 (14) |
RCA | 6 (43) | NA | 4 (57) | 2 (29) |
Pacing-response | ||||
Peak heart rate (bpm) | 146±16 | 150±18 | 144±11 | 145±22 |
Rate•pressure product (bpm•mmHg) | 21458±4216 | 22566±3028 | 20810±4662 | 21313±4892 |
Chest pain | 13 (68) | 2 (40) | 5 (71) | 6 (86) |
ST-segment depression | 9 (47) | 3 (60) | 2 (29) | 4 (57) |